Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2025
Summary of significant accounting policies
Accounts receivable	$ 71,848	$ 57,705
Compensation costs from contributions	1,400	1,100	$ 200
AstraZeneca | AZ Termination Agreement
Summary of significant accounting policies
Maximum potential payment per agreement				$ 75,000
Commercial customers
Summary of significant accounting policies
Accounts receivable	66,400	56,700
Collaborators
Summary of significant accounting policies
Accounts receivable	$ 5,400	$ 1,000
Minimum
Summary of significant accounting policies
Estimated useful lives	3 years
Maximum
Summary of significant accounting policies
Estimated useful lives	5 years